High Cholesterol Clinical Trial
Official title:
A Study on the Effect of Consuming a Herring Oil Concentrate on LDL Cholesterol Concentration in Adults With Overweight or Obesity
High cholesterol concentration is a major risk factor for cardiovascular disease (CVD), and consumption of fish has been associated with a lower CVD risk in several studies. The beneficial health effects of consuming fish have traditionally been ascribed to the long-chain PUFA (LC-PUFA) EPA (C20:5n-3) and DHA (C22:6n-3), although consumption of fish oils or concentrates with high EPA and DHA contents does not affect the cholesterol concentration in humans and lowers the cholesterol concentration in rats and mice only when given in very high doses. Fish oils contain a plethora of fatty acids besides EPA and DHA, and in recent years, increased focus has been on the long-chain MUFA (LC-MUFA) cetoleic acid (C22:1n-11). Cetoleic acid is found in high amounts in oils from certain fish species such as herring, which has relatively low contents of both EPA and DHA. The investigators have recently summarised and meta-analysed the available literature that investigates the effects of diets containing fish oils or fish oil concentrates that have a high content of cetoleic acid but low or no content of EPA and DHA on cholesterol concentration in rodents, showing that cetoleic acid-rich fish oils and concentrates prevent high cholesterol concentration.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT00965055 -
Ezetimibe in Patients Hypo-responsive to Statins
|
Phase 3 | |
| Completed |
NCT03542240 -
Effects of Curcumin Supplementation on Gut Barrier Function in Patients With Metabolic Syndrome
|
N/A | |
| Recruiting |
NCT06192251 -
Complete Lifestyle Medicine Intervention Program
|
||
| Completed |
NCT01004237 -
Additive Effects of Pravastatin and Valsartan
|
Phase 4 | |
| Completed |
NCT01187056 -
The RISAP-study: a Complex Intervention in Risk Communication and Shared Decision-making in General Practice
|
N/A | |
| Completed |
NCT06227819 -
BVA-200 vs BVA-100 Validation Study
|
||
| Completed |
NCT05266586 -
Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy
|
Phase 2 | |
| Completed |
NCT03084822 -
Cardiovascular Health Promotion Among African-Americans by FAITH!
|
N/A | |
| Completed |
NCT04317690 -
Online Trial Examining Validity and Reliability of the Shared Decision Making Process Survey
|
||
| Completed |
NCT04317274 -
Online Trial Examining Validity of the Shared Decision Making Process Survey With Video Vignettes
|
N/A | |
| Recruiting |
NCT06005597 -
Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies
|
Phase 3 | |
| Withdrawn |
NCT04510844 -
Evolocumab In Advanced Chronic Kidney Disease Trial
|
Phase 4 | |
| Completed |
NCT05421078 -
A Dose-Finding Study in Japanese Patients to Evaluate the Effect of Obicetrapib as an Adjunct to Stable Statin Therapy.
|
Phase 2 | |
| Completed |
NCT03528031 -
Habitual Diet and Avocado Trial
|
N/A | |
| Completed |
NCT04964544 -
Technology-Assisted Cholesterol Trial in Consumers (TACTiC)
|
Phase 3 | |
| Active, not recruiting |
NCT05425745 -
Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.
|
Phase 3 | |
| Completed |
NCT00833976 -
Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
|
Phase 4 | |
| Completed |
NCT00510809 -
Effect of Policosanol as Monotherapy and Adjunctive to Statin Therapy
|
N/A | |
| Terminated |
NCT04154579 -
Arts & Health Education to Improve Health, Resilience, and Well-Being
|
N/A | |
| Recruiting |
NCT06350604 -
Project WHADE: A Partner-Based Physical Activity Program for Women
|
N/A |